Philadelphia-Negative Neutrophilic Leukemias (CNL/aCML/MDS/MPNu)
Can it answer your research question?
1 of 6 supportedOverall survival
SupportedVital status and time are populated; median follow-up 1.6 years; 118 cases with follow-up; endpoint: overall survival.API
Progression or recurrence
Not supportedprogression_or_recurrenceis informative for no case in the harmonized records.APITreatment response
Not supportedtreatment_outcomeis populated for no case in the harmonized records.APIWhich drug was given
Not supportedtherapeutic_agentsis recorded for no case in the harmonized records.APIStage-adjusted modelling
Not supportedajcc_pathologic_stageis informative for no case in the harmonized records.APIAnalysis by race or ethnicity
Not supportedRace is informative for no case in the harmonized records.API
At a glance
Every percentage is the repository’s own record of what is filled inSubjectCALC
As filed by the repository
Who is in the cohortAPI
- Sex74 male · 39 female · 63 unknown
- Race176 not reported
- Ethnicity176 not reported
- Vital status54 dead · 8 alive · 65 unknown · 49 not reported
Age at diagnosis
How complete all 29 clinical fields are - 1 informative for at least 80% of cases
Outcome
Follow-up
Treatment
Diagnosis
Access
Data Access Request through dbGaP using an eRA Commons account; institutional signing official approval required
- Open components
- 80 open-access files
- Controlled components
- 1,548 controlled-access files
- Typical turnaround
- days to a few weeks after signing official approval
- License
- NIH Genomic Data Sharing Policy terms
- Citation requirement
- Cite the dataset accession and the program's publication guidelines; see the GDC publication policy.
What it is good for
Written and checked by a reviewer, not generated from metadata.
No reviewed research questions yet. The measurements and field completeness above are machine-extracted and still useful for judging fit.
What it cannot tell you
Written by a reviewer against the source, not inferred from what is missing.
No reviewed limitations yet. Check the field completeness chart above before committing to an analysis. Low coverage on an endpoint you need is the most common blocker.
Who has used it
Articles that analyzed these data, counted separately from articles that only cited the paper. Only the first counts as reuse.
What articles did with it
- Mentioned the dataset0
- Accession found in text0
- Declared using it1
- Analyzed the data1
Against comparable datasets
- Analyzed it1
- Expected~8
METHODS:"phs001799"), so every dataset in the corpus is counted the same way and the numbers can be compared. The 4 articles listed below were retrieved and graded one at a time, and an article counts as having analyzed the data wherever the accession sits in the analysis - methods, results, tables, figures or supplement - under any of this dataset’s accessions. Read the list as the evidence about these articles, and the count as the number that is comparable across datasets.- 1 article(s) reference this dataset's accession in a methods section, against 7.9 predicted for datasets of comparable size, age, modality breadth and access tier (reuse gap index -2.15 on a log2 scale, 8th percentile of the assessed corpus).
Articles that analyzed the data
Community examples
Share your exampleAnalyses someone ran on these data end to end, each with a receipt recording when it ran, against which packages and for how long.
Nobody has shared an analysis of this dataset yet. The examples on other datasets cover the common patterns and can be adapted - and if you adapt one, it belongs here.
Start here
Starter code generated from this record’s own identifiers, then the access steps.
Get the data in code
GDC: list open files and download thempython
import json, requests
PROJECT = "OHSU-CNL"
filters = {"op": "and", "content": [
{"op": "in", "content": {"field": "cases.project.project_id", "value": [PROJECT]}},
{"op": "in", "content": {"field": "access", "value": ["open"]}},
]}
params = {"filters": json.dumps(filters),
"fields": "file_id,file_name,data_category,data_type,file_size",
"size": "10000", "format": "JSON"}
files = requests.get("https://api.gdc.cancer.gov/files", params=params, timeout=60).json()["data"]["hits"]
print(len(files), "open files")
# Write a manifest and fetch with the GDC client (https://gdc.cancer.gov/access-data/gdc-data-transfer-tool)
with open("manifest.txt", "w") as fh:
fh.write("id\n" + "\n".join(f["file_id"] for f in files))
# $ gdc-client download -m manifest.txtGDC: clinical table for every casepython
import json, requests
filters = {"op": "in", "content": {"field": "project.project_id", "value": ["OHSU-CNL"]}}
params = {"filters": json.dumps(filters), "size": "5000", "format": "TSV",
"fields": ",".join([
"submitter_id", "demographic.vital_status", "demographic.days_to_death",
"diagnoses.days_to_last_follow_up", "diagnoses.ajcc_pathologic_stage",
"diagnoses.treatments.treatment_type", "diagnoses.treatments.treatment_outcome"])}
tsv = requests.get("https://api.gdc.cancer.gov/cases", params=params, timeout=60).text
open("OHSU-CNL_clinical.tsv", "w").write(tsv)This page as data: limitations firstbash
curl -s https://cd2s.vercel.app/data/datasets/gdc-ohsu-cnl.json | python3 -c '
import json, sys
r = json.load(sys.stdin)
for l in r["limitations"]:
print(l["severity"].upper(), "-", l["statement"][:120])
print("survival endpoint:", r["longitudinal"]["has_survival_endpoint"], "| treatment response:", r["longitudinal"]["has_treatment_response"])'Access steps
- Open the project in the GDC Data PortalFor people
Check the portal's current case and file counts before requesting anything; the cohort can change after this record was built.
https://portal.gdc.cancer.gov/projects/OHSU-CNL - Download the open files without an accountFor people
80 open-access files are marked open access. Add them to a portal cart, export a manifest, and fetch it with the GDC Data Transfer Tool.
https://gdc.cancer.gov/access-data/gdc-data-transfer-toolgdc-client download -m gdc_manifest.txt - Request controlled access through dbGaPFor people
1,548 controlled-access files require an approved data access request. The request starts at dbGaP, not in the portal. The relevant study is phs001799.
https://gdc.cancer.gov/access-data/obtaining-access-controlled-data - Download controlled files with your tokenFor people
An approved request yields a token. The same manifest fetches nothing controlled without it.
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001799gdc-client download -m gdc_manifest.txt -t gdc-user-token.txt - Query the project from code, with no credentialsFor agents
The file index is public even where files are not, so an agent can size the cohort before anyone requests access.
https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/curl -s 'https://api.gdc.cancer.gov/files' --get \ --data-urlencode 'filters={"op":"in","content":{"field":"cases.project.project_id","value":["OHSU-CNL"]}}' \ --data-urlencode 'fields=file_id,file_name,data_type' \ --data-urlencode 'size=10000' --data-urlencode 'format=TSV' - Pass the token when the agent needs controlled filesFor agents
Without a token, an API query may return only the open subset. Compare returned counts with the record before treating them as the whole cohort.
https://docs.gdc.cancer.gov/API/Users_Guide/Getting_Started/curl -H "X-Auth-Token: $GDC_TOKEN" https://api.gdc.cancer.gov/data/<file_id>
Provenance
All of it, and more, is in this record’s JSON.
Versions and verification
- Released
- 1 Jan 2019
- Metadata retrieved
- 18 Sept 2026
- Review status
- Machine-extracted
- Data generation funding
- Funded data generation
Funding
Funded reuse of these data
- R01CA183974Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven CancerJeffrey Wallace TynerAPI
- R00CA237630Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AMLHaijiao ZhangAPI
- R00CA190605Pathogenic Mechanisms of CSF3R Mutations in LeukemiaJulia E MaxsonAPI
- R00CA151457ROR1 as a Therapeutic Target in Acute Lymphoblastic LeukemiaJeffrey Wallace TynerAPI
- K99CA237630Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AMLHaijiao ZhangAPI
- K99CA190605Pathogenic Mechanisms of CSF3R Mutations in LeukemiaJulia E MaxsonAPI
Funded infrastructure or harmonization
- U54CA224019Architecture and Trajectory of Acquired Resistance to Therapy in AMLBRIAN J DRUKER, Shannon K. McWeeneyAPI
- U01CA217862Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic MalignanciesBRIAN J DRUKER, Jeffrey Wallace TynerAPI
- P30CA069533Cancer Center AdministrationMindy Roberts, Jeffrey Wallace TynerAPI
- P01CA066996Development of Novel Therapeutic Strategies in Human LeukemiasSCOTT A ARMSTRONG, DANIEL J DEANGELOAPI